301 related articles for article (PubMed ID: 22743037)
101. HIV/AIDS eradication.
Marsden MD; Zack JA
Bioorg Med Chem Lett; 2013 Jul; 23(14):4003-10. PubMed ID: 23735743
[TBL] [Abstract][Full Text] [Related]
102. Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice.
Halper-Stromberg A; Lu CL; Klein F; Horwitz JA; Bournazos S; Nogueira L; Eisenreich TR; Liu C; Gazumyan A; Schaefer U; Furze RC; Seaman MS; Prinjha R; Tarakhovsky A; Ravetch JV; Nussenzweig MC
Cell; 2014 Aug; 158(5):989-999. PubMed ID: 25131989
[TBL] [Abstract][Full Text] [Related]
103. Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure.
Armani-Tourret M; Bone B; Tan TS; Sun W; Bellefroid M; Struyve T; Louella M; Yu XG; Lichterfeld M
Nat Rev Microbiol; 2024 Jun; 22(6):328-344. PubMed ID: 38337034
[TBL] [Abstract][Full Text] [Related]
104. Finding a cure for human immunodeficiency virus-1 infection.
Blankson JN; Siliciano JD; Siliciano RF
Infect Dis Clin North Am; 2014 Dec; 28(4):633-50. PubMed ID: 25277513
[TBL] [Abstract][Full Text] [Related]
105. Macrophages: Key Cellular Players in HIV Infection and Pathogenesis.
Woottum M; Yan S; Sayettat S; Grinberg S; Cathelin D; Bekaddour N; Herbeuval JP; Benichou S
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400063
[TBL] [Abstract][Full Text] [Related]
106. Editorial: HIV Latency: novel insights into the viral reservoir and therapeutic strategies.
de Oliveira ACS; Abreu CM
Front Cell Infect Microbiol; 2024; 14():1434507. PubMed ID: 38947128
[No Abstract] [Full Text] [Related]
107. HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.
Battistini A; Sgarbanti M
Viruses; 2014 Apr; 6(4):1715-58. PubMed ID: 24736215
[TBL] [Abstract][Full Text] [Related]
108. From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.
Shan L; Siliciano RF
Bioessays; 2013 Jun; 35(6):544-52. PubMed ID: 23613347
[TBL] [Abstract][Full Text] [Related]
109. Towards an HIV-1 cure: measuring the latent reservoir.
Bruner KM; Hosmane NN; Siliciano RF
Trends Microbiol; 2015 Apr; 23(4):192-203. PubMed ID: 25747663
[TBL] [Abstract][Full Text] [Related]
110. Towards an HIV cure: a global scientific strategy.
; Deeks SG; Autran B; Berkhout B; Benkirane M; Cairns S; Chomont N; Chun TW; Churchill M; Di Mascio M; Katlama C; Lafeuillade A; Landay A; Lederman M; Lewin SR; Maldarelli F; Margolis D; Markowitz M; Martinez-Picado J; Mullins JI; Mellors J; Moreno S; O'Doherty U; Palmer S; Penicaud MC; Peterlin M; Poli G; Routy JP; Rouzioux C; Silvestri G; Stevenson M; Telenti A; Van Lint C; Verdin E; Woolfrey A; Zaia J; Barré-Sinoussi F
Nat Rev Immunol; 2012 Jul; 12(8):607-14. PubMed ID: 22814509
[TBL] [Abstract][Full Text] [Related]
111. Immune activation and HIV persistence: implications for curative approaches to HIV infection.
Klatt NR; Chomont N; Douek DC; Deeks SG
Immunol Rev; 2013 Jul; 254(1):326-42. PubMed ID: 23772629
[TBL] [Abstract][Full Text] [Related]
112. Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.
Ferretti F; Gisslen M; Cinque P; Price RW
Curr HIV/AIDS Rep; 2015 Jun; 12(2):280-8. PubMed ID: 25860317
[TBL] [Abstract][Full Text] [Related]
113. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression.
Claiborne DT; Prince JL; Scully E; Macharia G; Micci L; Lawson B; Kopycinski J; Deymier MJ; Vanderford TH; Nganou-Makamdop K; Ende Z; Brooks K; Tang J; Yu T; Lakhi S; Kilembe W; Silvestri G; Douek D; Goepfert PA; Price MA; Allen SA; Paiardini M; Altfeld M; Gilmour J; Hunter E
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1480-9. PubMed ID: 25730868
[TBL] [Abstract][Full Text] [Related]
114. Accurate episomal HIV 2-LTR circles quantification using optimized DNA isolation and droplet digital PCR.
Malatinkova E; Kiselinova M; Bonczkowski P; Trypsteen W; Messiaen P; Vermeire J; Verhasselt B; Vervisch K; Vandekerckhove L; De Spiegelaere W
J Int AIDS Soc; 2014; 17(4 Suppl 3):19674. PubMed ID: 25397424
[TBL] [Abstract][Full Text] [Related]
115. Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells.
Soriano-Sarabia N; Bateson RE; Dahl NP; Crooks AM; Kuruc JD; Margolis DM; Archin NM
J Virol; 2014 Dec; 88(24):14070-7. PubMed ID: 25253353
[TBL] [Abstract][Full Text] [Related]
116. Is the central nervous system a reservoir of HIV-1?
Gray LR; Roche M; Flynn JK; Wesselingh SL; Gorry PR; Churchill MJ
Curr Opin HIV AIDS; 2014 Nov; 9(6):552-8. PubMed ID: 25203642
[TBL] [Abstract][Full Text] [Related]
117. HIV-1 latency in monocytes/macrophages.
Kumar A; Abbas W; Herbein G
Viruses; 2014 Apr; 6(4):1837-60. PubMed ID: 24759213
[TBL] [Abstract][Full Text] [Related]
118. HIV accessory proteins versus host restriction factors.
Strebel K
Curr Opin Virol; 2013 Dec; 3(6):692-9. PubMed ID: 24246762
[TBL] [Abstract][Full Text] [Related]
119. Interleukin-7 promotes HIV persistence during antiretroviral therapy.
Vandergeeten C; Fromentin R; DaFonseca S; Lawani MB; Sereti I; Lederman MM; Ramgopal M; Routy JP; Sékaly RP; Chomont N
Blood; 2013 May; 121(21):4321-9. PubMed ID: 23589672
[TBL] [Abstract][Full Text] [Related]
120. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.
Eriksson S; Graf EH; Dahl V; Strain MC; Yukl SA; Lysenko ES; Bosch RJ; Lai J; Chioma S; Emad F; Abdel-Mohsen M; Hoh R; Hecht F; Hunt P; Somsouk M; Wong J; Johnston R; Siliciano RF; Richman DD; O'Doherty U; Palmer S; Deeks SG; Siliciano JD
PLoS Pathog; 2013 Feb; 9(2):e1003174. PubMed ID: 23459007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
